DERM NP/PA Conference (DERM), 2025

Bimekizumab long-term efficacy in patients with plaque psoriasis from BE BRIGHT: Improvements in mean absolute clinical outcome scores over 4 years

Gerdes Sascha, Costanzo Antonio, Fernandez-Peñas Pablo, et al.

Poster

Bimekizumab impact on flare in hidradenitis suppurativa over 2 years: Data from BE HEARD EXT

Naik B Haley, Daveluy Steven, Errol Prens, et al.

Poster

Bimekizumab efficacy and safety through 5 years in patients with moderate to severe plaque psoriasis in the US and Canada

Blauvelt Andrew, Khattri Saakshi, Rich Pheobe, et al.

Poster